97 related articles for article (PubMed ID: 29683132)
1. Correction: Evaluation of tenascin-C by tenatumomab in T-cell non-Hodgkin lymphomas identifies a new target for radioimmunotherapy.
Gritt G; Gianatt A; Petronzeii F; De Santis R; Pavoni C; Rossi RL; Cattaneo L; Spagnoli LG; Ferrar S; Ross A; Barbu AM; Rambald A
Oncotarget; 2018 Mar; 9(24):17256. PubMed ID: 29683132
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of tenascin-C by tenatumomab in T-cell non-Hodgkin lymphomas identifies a new target for radioimmunotherapy.
Gritti G; Gianatti A; Petronzelli F; De Santis R; Pavoni C; Rossi RL; Cattaneo L; Spagnoli LG; Ferrari S; Rossi A; Barbui AM; Rambaldi A
Oncotarget; 2018 Feb; 9(11):9766-9775. PubMed ID: 29515769
[TBL] [Abstract][Full Text] [Related]
3. Correction: Chidamide and decitabine can synergistically induce apoptosis of Hodgkin lymphoma cells by up-regulating the expression of PU.1 and KLF4.
Jiang T; Wang F; Hu L; Cheng X; Zheng Y; Liu T; Jia Y
Oncotarget; 2018 Apr; 9(30):21629. PubMed ID: 29766990
[TBL] [Abstract][Full Text] [Related]
4. Correction: Proteomic screening identifies the zonula occludens protein ZO-1 as a new partner for ADAM12 in invadopodia-like structures.
Dekky B; Ruff M; Bonnier D; Legagneux V; Théret N
Oncotarget; 2018 Nov; 9(87):35795. PubMed ID: 30515271
[TBL] [Abstract][Full Text] [Related]
5. Correction: The mutational landscape of ocular marginal zone lymphoma identifies frequent alterations in
Jung H; Yoo HY; Lee SH; Shin S; Kim SC; Lee S; Joung JG; Nam JY; Ryu D; Yun JW; Choi JK; Ghosh A; Kim KK; Kim SJ; Kim WS; Park WY; Ko YH
Oncotarget; 2018 Aug; 9(67):32882. PubMed ID: 30214692
[TBL] [Abstract][Full Text] [Related]
6. Correction: Screening of cancer tissue arrays identifies CXCR4 on adrenocortical carcinoma: correlates with expression and quantification on metastases using
Weiss ID; Huff LM; Evbuomwan MO; Xu X; Dang HD; Velez DS; Singh SP; Zhang HH; Gardina PJ; Lee JH; Lindenberg L; Myers TG; Paik CH; Schrump DS; Pittaluga S; Choyke PL; Fojo T; Farber JM
Oncotarget; 2018 Oct; 9(77):34641. PubMed ID: 30349656
[TBL] [Abstract][Full Text] [Related]
7. Radioimmunotherapy of non Hodgkins lymphomas.
Carrasquillo JA
Kaku Igaku; 2002 Sep; 39(3):229-30. PubMed ID: 12449555
[TBL] [Abstract][Full Text] [Related]
8. Correction: Overexpression of wildtype EGFR is tumorigenic and denotes a therapeutic target in non-small cell lung cancer.
Xu N; Fang W; Mu L; Tang Y; Gao L; Ren S; Cao D; Zhou L; Zhang A; Liu D; Zhou C; Wong KK; Yu L; Zhang L; Chen L
Oncotarget; 2018 Oct; 9(81):35284. PubMed ID: 30443296
[TBL] [Abstract][Full Text] [Related]
9. Correction: c-MET receptor as potential biomarker and target molecule for malignant testicular germ cell tumors.
Scheri KC; Leonetti E; Laino L; Gigantino V; Gesualdi L; Grammatico P; Bizzarri M; Franco R; Oosterhuis JW; Stoop H; Looijenga LHJ; Ricci G; Catizone A
Oncotarget; 2018 Nov; 9(89):36049. PubMed ID: 30542519
[TBL] [Abstract][Full Text] [Related]
10. Correction: Targeting a ribonucleoprotein complex containing the caprin-1 protein and the c-Myc mRNA suppresses tumor growth in mice: an identification of a novel oncotarget.
Qiu YQ; Yang CW; Lee YZ; Yang RB; Lee CH; Hsu HY; Chang CC; Lee SJ
Oncotarget; 2019 Aug; 10(47):4919. PubMed ID: 31448057
[TBL] [Abstract][Full Text] [Related]
11. Correction: Antigen-specific T cell Redirectors: a nanoparticle based approach for redirecting T cells.
Schütz C; Varela JC; Perica K; Haupt C; Oelke M; Schneck JP
Oncotarget; 2018 Aug; 9(64):32401. PubMed ID: 30190796
[TBL] [Abstract][Full Text] [Related]
12. Radioimmunotherapy for B-cell non-hodgkin lymphomas.
Tomblyn M
Cancer Control; 2012 Jul; 19(3):196-203. PubMed ID: 22710895
[TBL] [Abstract][Full Text] [Related]
13. Correction: Integrated epigenetic and genetic analysis identifies markers of prognostic significance in pediatric acute myeloid leukemia.
Lamba JK; Cao X; Raimondi SC; Rafiee R; Downing JR; Shi L; Gruber T; Ribeiro RC; Rubnitz JE; Pounds SB
Oncotarget; 2018 Jul; 9(54):30473. PubMed ID: 30101002
[TBL] [Abstract][Full Text] [Related]
14. Correction: Genetically enhanced T lymphocytes and the intensive care unit.
Tat T; Li H; Constantinescu CS; Onaciu A; Chira S; Osan C; Pasca S; Petrushev B; Moisoiu V; Micu WT; Berce C; Tranca S; Dima D; Berindan-Neagoe I; Shen J; Tomuleasa C; Qian L
Oncotarget; 2018 Aug; 9(62):32097. PubMed ID: 30174800
[TBL] [Abstract][Full Text] [Related]
15. Correction: Comparative oncology DNA sequencing of canine T cell lymphoma via human hotspot panel.
McDonald JT; Kritharis A; Beheshti A; Pilichowska M; Burgess K; Ricks-Santi L; McNiel E; London CA; Ravi D; Evens AM
Oncotarget; 2018 Sep; 9(70):33441. PubMed ID: 30279973
[TBL] [Abstract][Full Text] [Related]
16. Tenascin in reactive lymph nodes and in malignant lymphomas.
Soini Y; Alavaikko M; Lehto VP; Virtanen I
Pathol Res Pract; 1992 Dec; 188(8):1078-82. PubMed ID: 1284450
[TBL] [Abstract][Full Text] [Related]
17. Correction: MiR-124 acts as a target for Alzheimer's disease by regulating BACE1.
An F; Gong G; Wang Y; Bian M; Yu L; Wei C
Oncotarget; 2018 May; 9(37):24871. PubMed ID: 29873327
[TBL] [Abstract][Full Text] [Related]
18. Correction: Prorenin receptor acts as a potential molecular target for pancreatic ductal adenocarcinoma diagnosis.
Arundhathi A; Chuang WH; Chen JK; Wang SE; Shyr YM; Chen JY; Liao WN; Chen HW; Teng YM; Pai CC; Wang CH
Oncotarget; 2019 Jan; 10(4):558. PubMed ID: 30728905
[TBL] [Abstract][Full Text] [Related]
19. Correction: Acute myeloid leukemia with t(4;12)(q12;p13): an aggressive disease with frequent involvement of PDGFRA and ETV6.
Li J; Xu J; Abruzzo LV; Tang G; Li S; You MJ; Lu G; Jabbour EJ; Deng Q; Bueso-Ramos CE; Medeiros LJ; Yin CC
Oncotarget; 2018 Sep; 9(76):34449. PubMed ID: 30344953
[TBL] [Abstract][Full Text] [Related]
20. Correction: Endothelial microparticles delivering microRNA-155 into T lymphocytes are involved in the initiation of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.
Zhang R; Wang X; Hong M; Luo T; Zhao M; Shen H; Fang J; Li X; Zang S; Chen P; Nie D; Zheng P; Wu Q; Xia L
Oncotarget; 2017 Aug; 8(35):60000. PubMed ID: 28938702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
